JOY ONWUSIBE: Open Payments
NPI 1568718450 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$288 in 14 payments from 5 companies in 2025. Trend: 2023 $560 · 2024 $692 · 2025 $288
Food & beverage: $288
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $111 |
| ABBVIE INC. | 4 | $73 |
| Mallinckrodt Hospital Products Inc. | 3 | $59 |
| UCB, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: XIFAXAN, TERLIVAZ, DALVANCE, TEFLARO, Briviact.
Industry payments across GA — which companies pay providers there.
